Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
From CNBC.com News
From CNBC.com News
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
June 10, 2024
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
From CNBC.com News
Here's how U.S. health officials are responding to bird flu in humans after second case
May 24, 2024
From CNBC.com News
From CNBC.com News
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
May 13, 2024
From CNBC.com News
From CNBC.com News
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
May 10, 2024
From CNBC.com News
From CNBC.com News
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
May 01, 2024
From CNBC.com News
5 things to know before the stock market opens Monday
April 29, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
April 25, 2024
From CNBC.com News
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
April 25, 2024
From CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
From CNBC.com News
Cramer's Lightning Round: Leidos is a winner
March 28, 2024
From CNBC.com News
Moderna says new Covid vaccine showed stronger immune response than current shot in study
March 26, 2024
From CNBC.com News
From CNBC.com News
CNBC Daily Open: Conflicting signals on U.S. jobs market
March 11, 2024
From CNBC.com News
CNBC Daily Open: A mixed picture on U.S. jobs growth
March 10, 2024
From CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
